
Keren Osman, MD
Internal Medicine, Hematology-Oncology, Cancer (Oncology)
About Me
Keren Osman, MD, is Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai (ISMMS). She is the Medical Director of the Cellular Therapy Service in the Bone Marrow and Stem Cell Transplantation Program at The Tisch Cancer Institute and The Mount Sinai Hospital. Before joining the faculty at Mount Sinai, Dr. Osman spent three years as a Clinical Scholar in a Tumor Immunology Laboratory at The Rockefeller University, where she studied dendritic cell vaccines for the treatment of advanced cancers. Dr. Osman specializes in AL amyloidosis and cellular therapy applications, including CAR T-cell therapy, for the treatment of advanced blood and solid tumor cancers.
Learn more about the Cellular Therapy Service here: https://www.mountsinai.org/care/cancer/treatments/cellular-therapy
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
About Me
Keren Osman, MD, is Professor of Medicine, Hematology and Medical Oncology, at the Icahn School of Medicine at Mount Sinai (ISMMS). She is the Medical Director of the Cellular Therapy Service in the Bone Marrow and Stem Cell Transplantation Program at The Tisch Cancer Institute and The Mount Sinai Hospital. Before joining the faculty at Mount Sinai, Dr. Osman spent three years as a Clinical Scholar in a Tumor Immunology Laboratory at The Rockefeller University, where she studied dendritic cell vaccines for the treatment of advanced cancers. Dr. Osman specializes in AL amyloidosis and cellular therapy applications, including CAR T-cell therapy, for the treatment of advanced blood and solid tumor cancers.
Learn more about the Cellular Therapy Service here: https://www.mountsinai.org/care/cancer/treatments/cellular-therapy
Language
Position
Hospital Affiliations
- The Mount Sinai Hospital
Clinical Focus
- AL Amyloidosis
- Acute Lymphoid Leukemia
- Acute Myeloid Leukemia
- Adult Non-Hodgkin's Lymphoma
- Bone Marrow Transplantation
- Bone Marrow Transplantation, Allogeneic
- Bone Marrow Transplantation, Autologous
- Hematologic Malignancies
- Hematology
Show More
Video
Education
MD, Icahn School of Medicine at Mount Sinai
Residency, Internal Medicine
Mount Sinai Hospital
Fellowship, Medical Oncology
Memorial Sloan-Kettering Cancer Center
Certifications
American Board of Internal Medicine
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Ruttenberg Treatment Center1470 Madison Avenue, 3rd Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma. David G. Coffey, Keren Osman, Adolfo Aleman, Selma Bekri, Simone Kats, Amishi Dhadwal, Donna Catamero, Seunghee Kim-Schulze, Sacha Gnjatic, Ajai Chari, Samir Parekh, Sundar Jagannath, Hearn Jay Cho. Journal for ImmunoTherapy of Cancer
- CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease. Uroosa Ibrahim, Claude Bassil, Julio C. Chavez, Farhad Khimani, Michael D. Jain, Frederick L. Locke, Keren Osman, Aleksandr Lazaryan. Clinical Lymphoma, Myeloma and Leukemia
- Real-world evidence of the safety and survival with CD19 CAR-T cell therapy for relapsed/refractory solid organ transplant-related PTLD. Marshall McKenna, Narendranath Epperla, Armin Ghobadi, Jieqi Liu, Aleksandr Lazaryan, Uroosa Ibrahim, Caron A. Jacobson, Seema G. Naik, Loretta Nastoupil, Sayan Mullick Chowdhury, Timothy J. Voorhees, Miriam T Jacobs, Umar Farooq, Keren Osman, Adam J. Olszewski, Sairah Ahmed, Andrew M. Evens. British Journal of Haematology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Osman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Osman has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.